• FirefoxInstall the new Firefox »
  •  Dow Down0.45% Nasdaq Down0.49%

    Tekmira Pharmaceuticals Corp (TKMR)

    -NasdaqCM
    18.17 Down 0.22(1.20%) Feb 27, 4:00PM EST
    |After Hours : 18.00 Down 0.17 (0.94%) Feb 27, 7:18PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014
    Total Revenue 4,362   1,811   4,430  
    Cost of Revenue -   -   -  
    Gross Profit 4,362   1,811   4,430  
    Operating Expenses
    Research Development9,309  9,298  8,204  
    Selling General and Administrative1,764  1,787  2,050  
    Non Recurring -   -   -  
    Others133  149  134  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (6,844) (9,423) (5,958)
    Income from Continuing Operations
    Total Other Income/Expenses Net(1,760)3,342  (12,026)
    Earnings Before Interest And Taxes(8,604)(6,081)(17,984)
    Interest Expense -   -   -  
    Income Before Tax(8,604)(6,081)(17,984)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(8,604)(6,081)(17,984)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (8,604) (6,081) (17,984)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (8,604) (6,081) (17,984)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.